Why Novartis AG (VTX:NOVN) Could Have A Place In Your Portfolio
Attractive stocks have exceptional fundamentals. In the case of Novartis AG (VTX:NOVN), there’s is a highly-regarded dividend-paying company with a a great track record of delivering benchmark-beating performance. In the following section, I expand a bit more on these key aspects. For those interested in digger a bit deeper into my commentary, read the full report on Novartis here.
Solid track record established dividend payer
Over the past year, NOVN has grown its earnings by 64%, with its most recent figure exceeding its annual average over the past five years. Not only did NOVN outperformed its past performance, its growth also exceeded the Pharmaceuticals industry expansion, which generated a 18% earnings growth. This is an optimistic signal for the future.
Income investors would also be happy to know that NOVN is a great dividend company, with a current yield standing at 3.0%. NOVN has also been regularly increasing its dividend payments to shareholders over the past decade.
Next Steps:
For Novartis, there are three essential factors you should further examine:
Future Outlook: What are well-informed industry analysts predicting for NOVN’s future growth? Take a look at our free research report of analyst consensus for NOVN’s outlook.
Financial Health: Are NOVN’s operations financially sustainable? Balance sheets can be hard to analyze, which is why we’ve done it for you. Check out our financial health checks here.
Other Attractive Alternatives : Are there other well-rounded stocks you could be holding instead of NOVN? Explore our interactive list of stocks with large potential to get an idea of what else is out there you may be missing!
We aim to bring you long-term focused research analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.
If you spot an error that warrants correction, please contact the editor at editorial-team@simplywallst.com. This article by Simply Wall St is general in nature. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Simply Wall St has no position in the stocks mentioned. Thank you for reading.
